FDA allows involuntary research on patients Rules apply to gravely ill who are unable to consent
Vaccine has mixed reception Whooping cough preparation gauged
North American Vaccine is expanding It pays $25 million for nearby plant to handle increase in production
North American, Abbott sign vaccine agreement
'Orphan drug' finds a home Process: Developing a drug is only half the battle in treating rare diseases. The other half is finding a company to market the drug and seek FDA approval.
RU-486 shakes up abortion debate Non-surgical procedure: FDA approval will not settle contentious issue.
Sunny Cloud's plastic cup
FDA nears approval of abortion pill RU-486 appears safe, effective 'under close supervision,' it says; More information sought first; Abortion foes accuse agency of supporting 'a human pesticide'
FDA signs lease deal at Columbus Center
2-drug abortions set for test here Planned Parenthood is to begin trials at city clinic next year
Just when you thought it was safe to go out ...
Europe to try 'cardio-vest' first Device invented here still awaits U.S. OK, new FDA regulation
Nicotine's relationship to spinal disordersRecent Food and...
Fighting stroke damage Health: Advances in brain imaging and drugs lead to the conclusion that stroke is treatable as an emergency "brain attack."
Anastasia Nasis-Ravitz, 42, clinical pharmacistAnastasia E. "Staci"...
Clinton set to OK curbs on tobacco Proposed FDA rules will restrict marketing of cigarettes to teens; Political repercussions?; Tobacco companies, ad agencies expected to challenge in court
Hysteria is easier than science, and it pays better
New anti-stroke treatment must be delivered quickly
Liability for defective devices Supreme Court: Consumers win right to sue makers of faulty medical products.
Throwing more facts into fat-free fire
FDA urged to withdraw approval of olestra Group cites illnesses caused by fat substitute
First to receive a new heart defibrillator Taneytown resident gets high-tech model to control tachycardia condition
Sweetener has promise for diabetics Researcher says product doesn't raise blood sugar levels; Maker is Biospherics; Company can't afford clinical tests for FDA approval, official says
Medications can help fight obesityIn response to...
Obesity medicine worries doctors Deadly lung disease is feared as potential side effect of drug
Oncor's cancer-related test in line for FDA approval It is used to detect human papilloma virus
Guilford finds cure for an ailing stock Shares have soared in 12 months as the lab stirs up more winners; Pipeline flowing nicely; 'This has been like building a car while trying to drive it 70 mph'
Olestra battle crackling over 2 rival hot lines Fat substitute being test-marketed
Baltimore firm starts shipping generic treatment for baldness Barre-National pleased to challenge more costly Rogaine
Profits in animal dentistry entice 2 firms into alliance Nutramax will market USBiomaterials products
FDA warns of some Chinese herbal products' dangers Items are marketed as 'legal highs'
Deadly drug reactions are slow to surface
Banned sedative gets new chance Md. firm helping test thalidomide as a cancer treatment HTC
Columbus Center gets FDA operation Top seafood scientists to move into new lab at Inner Harbor site
Mystery project on the Inner Harbor Columbus Center: Multi-layered loan guarantees needed to open Inner Harbor exhibits.
Rockville company testing arthritis drug in Russia Human clinical studies cost much less there
Approval of RU-486 wouldn't rest debate Abortion drug moves closer to FDA review
Sensitive teeth, promising product USBiomaterials ready to talk with distributors pending FDA approval
FDA approves fake fat for use in snack foods despite its side effects Substitute Olestra has taste, adds no calories
Folks behind the food labels Details, details: Strict FDA regulations have given a local firm a full serving of business.
FDA OKs preemie vaccine MedImmune cleared to market RespiGam
Tobacco companies battle FDA plans Flurry of maneuvering closes comment period on cigarette regulation
Deadline near, FDA braces for flood of data on anti-tobacco plan Proposal aims to cut tobacco use by youngsters
MedImmune settles suit over stock
FDA panel backs Md. vaccine Final approval likely; MedImmune stock rises
Md. firm wins FDA approval of device to freeze, kill tissue Portable surgical probe to cost $125,000-$150,000
Oncor stock continues to fall Drop follows federal denial of marketing for breast cancer test
Oncor's breast cancer test isn't backed by FDA panel Company and analysts had been expecting an endorsement
Optimism greets FDA reforms Biotech firms predict easier medicine trials
Rationing bullets at the AlamoThe writer is...